ZA95521B - Watersoluble azole antifungals - Google Patents
Watersoluble azole antifungalsInfo
- Publication number
- ZA95521B ZA95521B ZA95521A ZA95521A ZA95521B ZA 95521 B ZA95521 B ZA 95521B ZA 95521 A ZA95521 A ZA 95521A ZA 95521 A ZA95521 A ZA 95521A ZA 95521 B ZA95521 B ZA 95521B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydrogen
- 6alkyl
- pct
- image
- watersoluble
- Prior art date
Links
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 title 2
- 229940121375 antifungal agent Drugs 0.000 title 1
- 239000001257 hydrogen Substances 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000005059 halophenyl group Chemical group 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- External Artificial Organs (AREA)
- Detergent Compositions (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18535294A | 1994-01-24 | 1994-01-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA95521B true ZA95521B (en) | 1996-07-23 |
Family
ID=22680644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA95521A ZA95521B (en) | 1994-01-24 | 1995-01-23 | Watersoluble azole antifungals |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US5707977A (pt) |
| EP (1) | EP0741737B1 (pt) |
| JP (1) | JP3764750B2 (pt) |
| KR (1) | KR100352147B1 (pt) |
| CN (1) | CN1078210C (pt) |
| AT (1) | ATE186540T1 (pt) |
| AU (1) | AU688455B2 (pt) |
| CA (1) | CA2179640C (pt) |
| CY (1) | CY2176B1 (pt) |
| CZ (1) | CZ288544B6 (pt) |
| DE (1) | DE69513279T2 (pt) |
| DK (1) | DK0741737T3 (pt) |
| ES (1) | ES2141329T3 (pt) |
| FI (1) | FI116057B (pt) |
| GR (1) | GR3032550T3 (pt) |
| HU (1) | HU227281B1 (pt) |
| IL (1) | IL112413A (pt) |
| LV (1) | LV12634B (pt) |
| MY (1) | MY111814A (pt) |
| NO (1) | NO308412B1 (pt) |
| NZ (1) | NZ278882A (pt) |
| PH (1) | PH31664A (pt) |
| PL (1) | PL181947B1 (pt) |
| PT (1) | PT741737E (pt) |
| RU (1) | RU2156764C2 (pt) |
| SG (1) | SG48386A1 (pt) |
| SI (1) | SI0741737T1 (pt) |
| SK (1) | SK282059B6 (pt) |
| TW (1) | TW376385B (pt) |
| WO (1) | WO1995019983A1 (pt) |
| ZA (1) | ZA95521B (pt) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW457240B (en) * | 1995-04-20 | 2001-10-01 | Janssen Pharmaceutica Nv | Novel triazolones as apolipoprotein-B synthesis inhibitors |
| ATE240319T1 (de) * | 1995-06-02 | 2003-05-15 | Schering Corp | Antifungale tetrahydrofurane |
| WO1997000255A1 (en) * | 1995-06-19 | 1997-01-03 | Schering Corporation | Tetrahydrofuran antifungals |
| US5698557A (en) * | 1995-06-19 | 1997-12-16 | Schering Corporation | Hydroxy-substituted antifungals |
| GB9602080D0 (en) * | 1996-02-02 | 1996-04-03 | Pfizer Ltd | Pharmaceutical compounds |
| NZ328607A (en) * | 1996-09-09 | 1999-08-30 | Hoffmann La Roche | Heterocyclically substituted n-benzyl-azolium derivatives and fungicidal compositions |
| EP0938484A1 (en) * | 1996-11-12 | 1999-09-01 | Sepracor, Inc. | 2r,4s,r,r- and 2s,4r,r,r-hydroxyitraconazole |
| CA2269608A1 (en) | 1996-11-12 | 1998-05-22 | Sepracor Inc. | 2r,4s,s,s- and 2s,4r,s,s-hydroxyitraconazole |
| WO1998021203A1 (en) * | 1996-11-12 | 1998-05-22 | Sepracor, Inc. | 2r,4s,s,r- and 2s,4r,s,r-hydroxyitraconazole |
| JP2001504121A (ja) * | 1996-11-12 | 2001-03-27 | セプラコール，インク． | ２ｒ，４ｓ，ｒ，ｓ―および２ｓ，４ｒ，ｒ，ｓ―ヒドロキシイトラコナゾール―およびヒドロキシサパーコナゾール誘導体 |
| DE69824834T2 (de) * | 1997-02-11 | 2005-07-21 | Janssen Pharmaceutica N.V. | Azole enthaltende antifungale aminosäure-ester |
| JP4473350B2 (ja) * | 1997-07-11 | 2010-06-02 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ２，４，４−三置換−１，３−ジオキソラン抗菌・抗カビ剤 |
| TW593312B (en) * | 1997-07-11 | 2004-06-21 | Janssen Pharmaceutica Nv | 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| PL189317B1 (pl) * | 1997-10-07 | 2005-07-29 | Schering Corp | Krystaliczny przeciwgrzybiczy polimorf (-)-4-[4-[4-[4-[(2R-cis)-5-(2,4-difluorofenylo)tetrahydro-5-(1H-1,2,4-triazol-1-ilo-metylo)furan-3-ilo]metoksy]fenylo]-1-piperazynylo]fenylo-2,4-dihydro-2-[(S)-1-etylo-2(S)-hydroksypropylo]-3H-1,2,4-triazol-3-onu |
| EP0957101A1 (en) * | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Water soluble azoles as broad-spectrum antifungals |
| US6265584B1 (en) * | 1998-05-22 | 2001-07-24 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
| AU1915500A (en) | 1998-11-20 | 2000-06-13 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
| US6362172B2 (en) | 2000-01-20 | 2002-03-26 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
| US6448401B1 (en) * | 2000-11-20 | 2002-09-10 | Bristol-Myers Squibb Company | Process for water soluble azole compounds |
| AR052342A1 (es) * | 2004-12-21 | 2007-03-14 | Janssen Pharmaceutica Nv | Derivados sustituidos de triazolona,tetrazolona e imidazolona con actividad selectiva antagonista de alfa2c-adenoreceptores |
| JO2691B1 (en) | 2005-05-03 | 2013-03-03 | ايساي آر آند دي مانجمنت كو.، ليمتد | Monolysine salts for azole compounds |
| JP2012502028A (ja) * | 2008-09-08 | 2012-01-26 | ウ，ニアン | トリアゾール抗真菌剤 |
| RU2563811C1 (ru) * | 2014-08-08 | 2015-09-20 | Федеральное государственное бюджетное учреждение науки Институт химической физики им. Н.Н. Семенова Российской академии наук (ИХФ РАН) | Фармацевтическая композиция для лечения грибковых заболеваний |
| CN106243087B (zh) * | 2016-09-12 | 2018-10-09 | 三峡大学 | 一种三唑吡咯烷酮类杀菌剂，合成方法及其应用 |
| CN111138421A (zh) * | 2019-12-26 | 2020-05-12 | 上海英诺富成生物科技有限公司 | 抗真菌水溶性化合物及其制备方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4218458A (en) * | 1978-06-23 | 1980-08-19 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
| CA1292472C (en) * | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| US4791111A (en) * | 1985-12-23 | 1988-12-13 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties |
| NZ223799A (en) * | 1987-03-25 | 1989-12-21 | Janssen Pharmaceutica Nv | Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions |
| US5039676A (en) * | 1990-05-11 | 1991-08-13 | Schering Corporation | Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
| IL103558A0 (en) * | 1991-10-30 | 1993-03-15 | Schering Corp | Tri-substituted tetrahydrofuran antifungals |
| AU681753B2 (en) * | 1993-12-21 | 1997-09-04 | Merck Sharp & Dohme Corp. | Tetrahydrofuran antifungals |
-
1995
- 1995-01-17 NZ NZ278882A patent/NZ278882A/en not_active IP Right Cessation
- 1995-01-17 DK DK95906968T patent/DK0741737T3/da active
- 1995-01-17 KR KR1019960703394A patent/KR100352147B1/ko not_active IP Right Cessation
- 1995-01-17 WO PCT/EP1995/000174 patent/WO1995019983A1/en active IP Right Grant
- 1995-01-17 CA CA002179640A patent/CA2179640C/en not_active Expired - Lifetime
- 1995-01-17 PT PT95906968T patent/PT741737E/pt unknown
- 1995-01-17 SK SK896-96A patent/SK282059B6/sk not_active IP Right Cessation
- 1995-01-17 DE DE69513279T patent/DE69513279T2/de not_active Expired - Lifetime
- 1995-01-17 AU AU15355/95A patent/AU688455B2/en not_active Expired
- 1995-01-17 US US08/666,270 patent/US5707977A/en not_active Expired - Lifetime
- 1995-01-17 PL PL95315558A patent/PL181947B1/pl unknown
- 1995-01-17 AT AT95906968T patent/ATE186540T1/de active
- 1995-01-17 RU RU96117244/04A patent/RU2156764C2/ru active
- 1995-01-17 HU HU9602008A patent/HU227281B1/hu unknown
- 1995-01-17 JP JP51933795A patent/JP3764750B2/ja not_active Expired - Lifetime
- 1995-01-17 CN CN95191237A patent/CN1078210C/zh not_active Expired - Lifetime
- 1995-01-17 SI SI9530327T patent/SI0741737T1/xx unknown
- 1995-01-17 ES ES95906968T patent/ES2141329T3/es not_active Expired - Lifetime
- 1995-01-17 SG SG1996009270A patent/SG48386A1/en unknown
- 1995-01-17 EP EP95906968A patent/EP0741737B1/en not_active Expired - Lifetime
- 1995-01-17 CZ CZ19961956A patent/CZ288544B6/cs not_active IP Right Cessation
- 1995-01-19 PH PH49798A patent/PH31664A/en unknown
- 1995-01-20 MY MYPI95000141A patent/MY111814A/en unknown
- 1995-01-23 ZA ZA95521A patent/ZA95521B/xx unknown
- 1995-01-23 TW TW084100675A patent/TW376385B/zh not_active IP Right Cessation
- 1995-01-23 IL IL11241395A patent/IL112413A/xx not_active IP Right Cessation
-
1996
- 1996-07-23 NO NO963073A patent/NO308412B1/no not_active IP Right Cessation
- 1996-07-23 FI FI962947A patent/FI116057B/fi not_active IP Right Cessation
-
2000
- 2000-02-02 GR GR20000400246T patent/GR3032550T3/el unknown
- 2000-06-16 CY CY0000029A patent/CY2176B1/xx unknown
- 2000-11-09 LV LVP-00-153A patent/LV12634B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA95521B (en) | Watersoluble azole antifungals | |
| BG102077A (en) | Isothiazolons | |
| CA2285891A1 (en) | Triazole antifungal agents | |
| MX9700340A (es) | Agentes anti-helicobacter derivados sulfonamida de azolonas. | |
| CA2045359A1 (en) | 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines | |
| GB9121456D0 (en) | Triazole antifungal agents | |
| IL110328A0 (en) | Derivatives of imidazo(1,2,a) pyrazin-4-one, their preparation and medicaments containing them | |
| GB2211186B (en) | Chemical compounds | |
| DE69104475D1 (de) | Harnstoffderivate, ihre herstellung und deren enthaltende arzneimittel. | |
| TW350757B (en) | Benzisoxazole derivatives and pesticidal compositions containing them | |
| TW354780B (en) | 2-disubstituted cyclohexenyl and cyclohexyl antimicrobial agents | |
| ES2112151A1 (es) | Nuevos compuestos homoquirales para la preparacion de ketoconazol, terconazol y antifungicos relacionados, procedimiento para su fabricacion y utilizacion de los mismos. | |
| AU6876896A (en) | Carbamoylcarboxamides | |
| MY130817A (en) | Herbicides | |
| AU9426098A (en) | Azetidinone derivatives for the treatment of hcmv infections | |
| TW269680B (pt) | ||
| GR3025116T3 (en) | Process for the preparation of n-carbonylarylimines useful for the synthesis of therapeutically active taxoids | |
| MY118844A (en) | 2,4,4-trisubstituted-1,3-dioxolane antifungals | |
| UA70917C2 (uk) | Похідні оксадіазину, інсектицидна композиція та спосіб боротьби з комахами | |
| TW358090B (en) | <beta>-adrenergic agonists |